UPCC 31524 Increasing Adoption of a Telehealth-Delivered Collaborative Care Program for Patients with Lung Cancer: A Pilot Study

Investigating Remote Healthcare Services Using Digital Communication Tools for Collaborative Care in Lung Cancer Patients

Enrolling By Invitation
18 years or above
All
Phase N/A
30 participants needed
1 Location

Brief description of study

The goal of this trial is to compare the impact of two outreach strategies (high touch vs. standard outreach) on a collaborative care program delivered via telehealth to patients with lung cancer.

Detailed description of study

The goal of this project is to pilot test the effectiveness of using a more-intensive (high touch) outreach strategy to increase the reach of an adapted, standard of care CoCM for patients with lung cancer who are experiencing depression and/or anxiety. The investigators will specifically test the effect of two outreach strategies (high touch vs. standard outreach) on reach of the CoCM program (primary outcome) and on several secondary implementation and effectiveness outcomes. Given the demonstrated efficacy of the CoCM in patients with cancer, the main target of this research study is the impact of the outreach strategies and delivery of the CoCM via telehealth.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Lung Cancer (Diagnosis), Anxiety, Depression in Adults
  • Age: 18 years or above
  • Gender: All

Inclusion Criteria:

  • Are aged 18 years or older.
  • Are currently being seen by Penn Medicine Thoracic Oncology for lung cancer treatment or survivorship care.
  • Are referred to collaborative care by a Penn Medicine Thoracic Oncology clinician for treatment of depression, anxiety, or other psycho-therapy services.

Exclusion Criteria:

  • Are already receiving psycho-therapy treatment services outside of Penn Medicine's collaborative care program, Penn Integrated Care (PIC).
  • Have a significant and/or untreated medical and/or psychiatric co-morbidity (e.g., other cancers, schizophrenia, acute suicidal and/or homicidal ideation) that make them ineligible for the Penn CoCM program.

This study investigates the impact of different outreach strategies on a telehealth-delivered collaborative care program for patients with lung cancer. The purpose is to compare two approaches: a more intensive 'high touch' strategy versus a standard outreach. The study focuses on patients who are experiencing depression and/or anxiety, which are often associated with lung cancer, to see how these strategies affect the reach and effectiveness of the care program.

Participants will be involved in a collaborative care model (CoCM), a structured approach to managing mental health conditions like depression and anxiety. This model will be delivered through telehealth, meaning that participants will receive care remotely, using digital communication tools. The study will evaluate the primary outcome of the reach of the CoCM program and several secondary outcomes related to its implementation and effectiveness.

  • Who can participate: Adults aged 18 years or older who are receiving treatment or survivorship care for lung cancer at Penn Medicine Thoracic Oncology and have been referred for collaborative care to address depression, anxiety, or related issues can participate.
  • Study details: Participants will engage in a telehealth-delivered collaborative care program designed to address mental health needs such as depression and anxiety. They will be part of a study that tests the effectiveness of different outreach strategies to enhance the program's reach.
Updated on 28 May 2026. Study ID: 24-2186
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator